Skip to content

What are the ingredients in caffeine citrate?

4 min read

According to the FDA, caffeine citrate injection is prepared by combining caffeine anhydrous, citric acid monohydrate, and sodium citrate dihydrate with Water for Injection. This formulation is primarily used in the medical field to treat breathing problems in premature infants. Understanding what are the ingredients in caffeine citrate helps explain its enhanced properties over pure caffeine.

Quick Summary

A detailed look at the core components of caffeine citrate, including its active and inactive ingredients. Learn how its unique formulation enhances solubility, stability, and tolerability for specific medical uses.

Key Points

  • Core Ingredients: The primary components of caffeine citrate are anhydrous caffeine and citric acid monohydrate, often formulated with sodium citrate dihydrate and Water for Injection.

  • Purpose of Formulation: The citrate formulation increases the solubility and stability of caffeine, making it easier to administer as a liquid solution.

  • Main Medical Use: It is a prescription medication primarily used to treat apnea of prematurity, a condition where premature infants experience temporary cessation of breathing.

  • Mechanism of Action: Caffeine citrate works by stimulating the central nervous system and respiratory centers by blocking adenosine receptors in the brain.

  • Preferred Treatment: In neonatal care, caffeine citrate is often the preferred methylxanthine due to its wider therapeutic index and lower risk of side effects compared to drugs like theophylline.

  • Manufacturing Process: Producing the medication involves controlled dissolution, pH adjustment, and sterile filtration to ensure a safe, high-quality final product.

  • Dosage and Monitoring: Precise dosing is critical, especially in neonates, with serum caffeine levels sometimes needing monitoring to prevent toxicity.

In This Article

Core Active and Inactive Ingredients

Caffeine citrate is not a simple combination but a specific chemical formulation designed for medical use, particularly for treating apnea of prematurity in newborns. The preparation is a co-crystal of caffeine and citric acid, often requiring other ingredients for stability and solubility, especially in liquid forms.

Primary Active Ingredient: Caffeine Anhydrous

At its core, the active component of caffeine citrate is anhydrous caffeine.

  • Source: While caffeine can be sourced naturally from plants like coffee beans, pharmaceutical-grade anhydrous caffeine is typically synthesized.
  • Function: In its pure form, caffeine acts as a central nervous system stimulant, but its low solubility in water at room temperature makes it challenging for immediate therapeutic use.

Buffering and Solubilizing Agents

To overcome the solubility issues of pure caffeine, buffering agents are added to the formulation.

  • Citric Acid Monohydrate: This is the 'citrate' part of the name. It combines with anhydrous caffeine to form the more soluble caffeine citrate salt. Citric acid helps adjust the pH of the solution and enhances overall stability.
  • Sodium Citrate Dihydrate: Added alongside citric acid to act as a buffering agent. It helps maintain a stable pH for the solution, preventing precipitation and ensuring the medication remains effective.
  • Water for Injection: This is the sterile, non-pyrogenic solvent in which the active and buffering ingredients are dissolved to create the final solution.

Comparison of Caffeine Citrate and Anhydrous Caffeine

To highlight the importance of the citrate formulation, the following table compares key characteristics of caffeine citrate with its parent compound, caffeine anhydrous.

Feature Caffeine Citrate Caffeine Anhydrous
Composition Co-crystal of caffeine and citric acid. Pure, synthesized xanthine alkaloid.
Solubility in Water Highly soluble in water, making it suitable for intravenous and oral solutions. Sparingly soluble in water at room temperature.
Application Primarily used as a prescription medication for neonatal apnea. Used in a wider range of products, including OTC medications, supplements, and food additives.
Bioavailability Administered as a more stable, readily absorbed solution. Can be less stable and less consistent in liquid formulation without buffering agents.
Therapeutic Index Has a wider therapeutic index and is generally better tolerated in clinical settings than other methylxanthines. Dosing requires careful distinction as the citrate form is a larger molecule for the same amount of caffeine.

Synthesis and Manufacturing Process

The production of pharmaceutical-grade caffeine citrate involves a precise manufacturing process to ensure the final product is sterile, pure, and effective.

Step-by-Step Synthesis

  1. Preparation: The process begins with dissolving high-purity anhydrous caffeine and citric acid monohydrate in Water for Injection at a specific temperature.
  2. pH Adjustment: Sodium citrate dihydrate is added to the solution to achieve the desired pH range, typically between 4.5 and 5.0. This crucial step is what makes the final solution stable and ready for use.
  3. Filtration and Sterilization: The solution is then subjected to fine filtration and sterile filtration to remove any impurities or particulate matter. This step is critical for a product intended for intravenous or oral administration to premature infants.
  4. Packaging: The finished product is filled into sterile containers, such as single-dose glass vials, in a controlled, nitrogen-filled environment to maintain stability.

The Role of Each Ingredient in the Final Product

Every ingredient serves a specific purpose in the final caffeine citrate solution. Anhydrous caffeine provides the therapeutic effect, but the citrate compounds make the delivery possible. Without the inclusion of citric acid and sodium citrate, a stable, sterile, and tolerable liquid medication would be challenging to create, especially for the sensitive patient population of preterm infants. The combination allows for precise, predictable dosing, which is essential for managing critical conditions like apnea of prematurity.

Conclusion

In summary, the ingredients in caffeine citrate are not merely a mixture of caffeine and citric acid but a carefully engineered formulation. The primary active component is caffeine anhydrous, which is combined with citric acid monohydrate and sodium citrate dihydrate to enhance its solubility, stability, and overall tolerability. This chemical sophistication is what makes it a suitable and effective medication for treating a lack of breathing in premature infants. The precise combination of ingredients and strict manufacturing protocols ensure a safe, sterile product for a vulnerable patient population, illustrating the complex science behind pharmaceutical development.

How it works: Blocking Adenosine

One of the primary mechanisms by which caffeine citrate functions is its ability to act as an adenosine receptor antagonist. Adenosine is a compound in the body that can cause sedation and respiratory depression by acting on adenosine A1 and A2A receptors. By blocking these receptors, caffeine stimulates the central nervous system, increases the respiratory rate, and improves the overall control of breathing. This is the key pharmacological action that makes it a drug of choice for treating apnea of prematurity. This effect also explains why it is preferred over other methylxanthines like theophylline, as it offers a wider therapeutic window with fewer side effects.

Important Considerations for Use

Despite its effectiveness, it's vital to recognize that caffeine citrate is a prescription medication requiring careful administration, especially in neonates. Dosage is based on body weight and must be meticulously monitored to avoid toxicity, as high serum levels can lead to adverse effects. Premature infants, whose liver and kidney function are still developing, clear caffeine much slower than adults, further necessitating careful dosage management. Healthcare professionals must also rule out other potential causes of apnea before initiating treatment. It is not a substitute for coffee or other caffeine products and should only be used under strict medical supervision.

Frequently Asked Questions

The primary function of caffeine citrate's ingredients is to create a stable, soluble, and tolerable form of caffeine for medical use. Anhydrous caffeine provides the therapeutic stimulation, while citric acid and sodium citrate act as a solubilizing and buffering system.

Caffeine citrate differs from pure caffeine by its formulation with citric acid, which significantly improves its solubility in water. This makes it suitable for intravenous and oral solutions, especially for delicate patients like premature infants.

Citric acid is included to form the highly soluble salt caffeine citrate and to act as a pH adjuster. Along with sodium citrate, it helps maintain the solution's stability and pH balance.

Yes, caffeine citrate is considered the drug of choice for treating apnea of prematurity in infants, and it has been shown to be effective and generally well-tolerated in clinical studies. However, as with any medication, close medical supervision is required.

Yes, commercially available caffeine citrate solutions, like those for injection, include Water for Injection, USP, in addition to the active ingredients and buffering salts. Other preparations might contain additional stabilizing agents.

The dosage is typically determined based on the patient's body weight and is calculated differently for the loading dose and daily maintenance dose. Doses are often expressed as caffeine citrate, which is roughly double the dose of caffeine base.

Yes, especially in newborns with immature liver or kidney function, serum concentrations of caffeine may need to be periodically monitored to avoid toxicity. Serious toxicity can occur if serum levels exceed certain thresholds.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.